An FDA approved anti psychotic drug is proving to be effective in killing glioblastoma brain cancer tumors, a new study reports.
A new study reports researchers have identified a mechanism that aids the growth of glioblastoma brain cancer. By blocking the mechanism, researchers were able to halt the progression of the tumors.
Researchers have identified specific chemical changes in the brain that drive nicotine addiction. The findings could lead to new treatments to help break the addiction.
Using stem cells from candidates with Down syndrome to create an organoid, and employing mouse models, researchers pinpoint a gene linked to memory impairments and cognitive problems in Down syndrome. Inhibiting the OLIG2 gene leads to cognitive and memory improvements in mouse models of Down. Researchers hope their findings lead to an in utero treatment that targets the gene and helps reverse abnormal brain development.